Gene: NACA2
Official Full Name: nascent polypeptide associated complex subunit alpha 2provided by HGNC
Gene Summary: Predicted to enable unfolded protein binding activity. Predicted to be involved in protein targeting to membrane. Predicted to be located in nucleus. Predicted to be part of nascent polypeptide-associated complex. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15903 | NACA2 Knockout cell line (HeLa) | Human | NACA2 | 1:3~1:6 | Negative | Online Inquiry |
KO15904 | NACA2 Knockout cell line (HCT 116) | Human | NACA2 | 1:2~1:4 | Negative | Online Inquiry |
KO15905 | NACA2 Knockout cell line (A549) | Human | NACA2 | 1:3~1:4 | Negative | Online Inquiry |
NACA2 Gene Knockout Cell Lines are advanced cellular models designed for in-depth genetic studies and functional analyses of the NACA2 gene, an important player in cellular processes such as ribosomal protein assembly and stress response pathways. By utilizing CRISPR-Cas9 genome editing technology, these cell lines have been precisely engineered to possess a complete knockout of the NACA2 gene, allowing researchers to explore its role in various biological contexts.
The primary function of NACA2 Gene Knockout Cell Lines lies in their ability to provide a controlled environment to study the downstream effects of NACA2 absence, facilitating investigations into alterations in protein synthesis, cellular stress responses, and overall cell viability. These models enable researchers to elucidate the physiological and pathological implications of NACA2 gene dysregulation, offering insights that are crucial for understanding diseases such as cancer and neurodegenerative disorders.
The scientific importance of these cell lines is underscored by their application in both basic research and clinical settings. Researchers can utilize NACA2 knockouts to evaluate the potential of therapeutic targets and to assess the impact of various compounds in a genetically modified context, thus contributing to the development of novel interventions. Furthermore, they serve as invaluable tools for drug discovery, biomarker identification, and the validation of genetic hypotheses.
What sets NACA2 Gene Knockout Cell Lines apart from traditional cell models is their precise genetic alteration, which minimizes off-target effects commonly associated with previous gene editing techniques. Additionally, the reproducibility of results obtained from these cell lines enhances the reliability of the data, making them a preferred choice for researchers who demand high-quality models.
Investing in NACA2 Gene Knockout Cell Lines empowers researchers and clinicians to push the boundaries of genetic research with confidence. Our company, renowned for its commitment to scientific excellence, provides these premium cell lines, supported by rigorous validation and a comprehensive understanding of their applications, ensuring that you have the right tools to advance your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.